Idorsia Ltd (LON:0RQE)
London · Delayed Price · Currency is GBP · Price in CHF 3.853
-0.078 (-1.99%)
At close: Feb 12, 2026
Idorsia Market Cap
Idorsia has a market cap or net worth of 925.47 million as of February 12, 2026. Its market cap has increased by 660.12% in one year.
Market Cap
925.47M
Enterprise Value
2.06B
Revenue
216.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.85
Market Cap Chart
Since June 16, 2017, Idorsia's market cap has decreased from 1.31B to 925.47M, a decrease of -29.14%. That is a compound annual growth rate of -3.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 916.44M | -8.15% |
| Dec 30, 2025 | 997.71M | 631.50% |
| Dec 30, 2024 | 136.39M | -61.18% |
| Dec 29, 2023 | 351.34M | -83.57% |
| Dec 30, 2022 | 2.14B | -20.00% |
| Dec 30, 2021 | 2.67B | -24.40% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 2.09B |
| Oxford Nanopore Technologies | 1.40B |
| Oxford Biomedica | 998.08M |
| PureTech Health | 312.74M |
| Avacta Group | 260.26M |
| Scancell Holdings | 128.68M |
| Bioventix | 92.74M |
| 4basebio | 91.32M |